Elective endovascular stent-grafting of abdominal aortic aneurysms Hobo, R.
Introduction
Endovascular stent-grafting is a popular treatment for abdominal aortic aneurysms (AAA). [1] [2] [3] Due to ongoing technical evolution of stent-grafts the indications for endovascular aneurysm repair (EVAR) have widened. 4 Patients with co-morbidities or complex aneurysm anatomy often require adjuvant procedures. [5] [6] [7] Moreover, adjuvant procedures are used to resolve intraoperative pitfalls. 8 Adjuvant procedures may be performed for gaining access to the aneurysm in case of tortuous or occluded iliac arteries, for better anchoring the device in case of imperfect fixation and for preserving the blood flow to peripheral arteries. Thus, many patients, who otherwise would be treated by open repair, can undergo endovascular repair by employing additional techniques. 7, 9, 10 There are few reports on the outcome of adjuvant procedures performed during EVAR. 8, 9, 11 The objective of this study was to compare the early and late outcome of endovascular repair requiring adjuvant procedures with uncomplicated endovascular therapy.
Materials and methods
Design Data was retrieved from the European collaborators on stent-graft techniques for abdominal aortic aneurysm repair (EUROSTAR) registry. 12, 13 This multi-centre voluntary registry was established in 1996 with the objective of collecting and analysing data from AAA patients undergoing endovascular treatment with commercially available self-expanding stent-grafts, including Talent (AVE/Medtronic, Sunrise, Fla), AneuRx (AVE/Medtronic), Zenith (William Cook, Bloomington, Indiana), Excluder (Gore and associates, Newark, DE), Fortron (Cordis, Waterloo, Belgium) and Lifepath (Edwards, Irvine, Calif). The operative procedure has been described in detail previously. 14, 15 Patients with a non-ruptured, asymptomatic AAA were selected for elective endovascular surgery. All patients had read the patient information and consent was obtained. Enrollment in the registry was prospective on an intention-to-treat basis to prevent selection bias. Patients who were treated before the commencement of the registry (the retrospective cohort) were excluded from the analysis. Participating physicians had to complete a standardised case record form (CRF) for submitting to the registry centre. Since 2002, patient data could be entered online into the EUROSTAR database via the website www.eurostar-online.org (KIKA Medical, Nancy, France).
Demographic information of the patient, risk factors according to SVS-ISCVS risk score, aortic anatomic characteristics assessed by enhanced 75 computer tomography (CT) and angiography, operative technical and procedural details, mortality, endoleaks, complications, secondary interventions and ruptures were recorded. Findings at clinical examination and CT assessment, angiography, magnetic resonance imaging (MRI) or duplex ultrasound scanning (DUS) during follow-up were recorded at 1, 3, 6, 12, 18 and 24 months and annually thereafter. The patient series analysed in this report was enrolled between October 1996 and November 2003.
Early and late outcome were compared between patients without (group D) and with intraoperative adjuvant procedures. The latter category is subdivided into endovascular (group A), surgical peripheral arterial, including groin procedures (group B) and surgical abdominal arterial (group C) adjuvant procedures. Patients who had more than one adjuvant procedure were assigned to the group according to their most invasive intervention. Crossover femoro-femoral bypasses and occluders in patients with an aortouniiliac stent-graft and endograft extensions were not regarded as an adjuvant procedure. Patients with a maximal aneurysm diameter of less than 40 mm (N=248), patients with missing operation data (N=62) and patients with stent-grafts that are now withdrawn from the market (N=1365) were excluded from this study.
Outcome variables
Early complications were divided into device migration, graft thrombosis, arterial thrombosis, emboli, endoleaks at the completion angiogram, systemic complications, 30-day conversion, rupture and mortality. Intraoperative adverse events were not regarded as outcome measures. Late outcome events included endoleaks, endograft migration, kinking, stenosis and thrombosis. Moreover, AAA rupture, aneurysmal growth (defined as an 8 mm increase from the preoperative measurement), secondary intervention and all-cause and aneurysm-related mortality were assessed as outcome events. Aneurysm-related mortality was defined as death within 30 days of initial or secondary intervention or associated with rupture or endograft infection. Reporting was in accordance with the guidelines of the ad hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery. 16 
Statistical analysis
Univariate chi-square tests and multivariate logistic regression analysis were performed to study the differences in procedural outcome and mortality between patients with and without adjuvant procedures. Kaplan-Meier analysis and Cox proportional hazards model were used to assess the differences in late outcome and mortality. The results of the comparisons were expressed as odds ratios (OR) or hazard ratios (HR) with corresponding 95% confidence interval (CI). Adjustment for patient, anatomic, procedure and physician factors; including age, gender, anatomic characteristics, type of stent-graft, year of procedure and team experience were made. A p value less than .05 was required to achieve statistical significance. All analyses were performed with the SAS system (version 8.00, SAS Institute, Cary, North Carolina).
Results

Patients
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Adjuvant procedures during endovascular repair Table 1 Note: 1154 patients had 1228 endovascular procedures. One thousand and fifty-seven of them had no surgical adjuvant procedures and were assigned to group A. From 199 patients with peripheral surgical adjuvant procedures six had also surgical abdominal procedures and were assigned to group C. * Crossover femoro-femoral bypass with an aortouniiliac stent was not regarded as an adjuvant procedure.
. Classification of adjuvant procedures
In total 4631 patients from 146 centres were included in the study-group. One thousand three hundred and fifty-three patients (29.2%) required 1531 adjuvant procedures ( Percutaneous transluminal angioplasty (PTA) (55.5%) and coil embolisation (39.7%) were the most frequently performed endovascular adjuvant procedures. Endarterectomy (35.2%) and crossover femoro-femoral bypass (23.6%) were the most frequent surgical peripheral adjuvant procedures and iliofemoral bypass for access (41.4%) was the most frequent surgical abdominal adjuvant procedure. Females required significantly more peripheral surgical adjuvant procedures than males (p=0.009) ( Table 2) .
Early outcome
The 30-day mortality was significantly higher in group B (OR: 3.0, 95% CI: 1.5-6.1, p=0.001) and group C (OR: 4.0, 95% CI: 1.8-9.2, p=0.004) compared with group D ( Table 3) . Rupture and conversion rates in the first 30 days were not significantly different between procedural categories.
79
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P-values represent significant differences compared with group D.
Primary conversion on the first day was less frequently performed in group A (OR: 0.2, 95% CI: 0.0-0.9, p=0.37). There was only one rupture in the first month in the whole study group. Device migration and graft thrombosis were not increased in the early postoperative phase in any adjuvant procedure category. The prevalence of arterial thrombosis was significantly higher in patients with endovascular (OR: 3.1, 95% CI: 1.2-7.8, p=0.023) and surgical peripheral adjuvant procedures (OR: 11.4, 95% CI: 3.8-34.1, p<0.001) compared with the control group. Emboli were observed more frequently in the category of surgical peripheral adjuvant procedures (OR: 4.2, 95% CI: 1.1-16.4, p=0.032) and of surgical abdominal adjuvant procedures (OR: 6.7, 95% CI: 1.7-27.3, p=0.005) than in the control group. The incidence of endoleaks at the completion angiogram, combined types and specific types, was not increased in any group. Systemic complications combined (p=0.011 for group A, p=0.002 for group B and p=0.011 for group C) correlated significantly with any adjuvant procedure. In particular, an increased incidence in hepatobiliary (OR: 16.7, 95% CI: 2.3-120, p=0.008) and bowel (OR: 6.3, 95% CI: 2.6-15.1, p<0.001) complications in group B was notable.
Outcome at follow-up
Life table analysis (Fig. 1 ) demonstrated a significantly higher overall mortality in patients with surgical abdominal adjuvant procedures (HR: 2.0, 95% CI: 1.2-3.6, p=0.012) compared with un-assisted procedures.
However, the late mortality (>30 days) was not increased (Fig. 2) . The aneurysm-related mortality was increased in patients with surgical peripheral arterial and in patients with surgical abdominal adjuvant procedures compared with patients without adjuvant procedures (p=0.026 and p<0.001, respectively). The incidence of secondary interventions during follow-up (including conversion to open surgery, femoro-femoral bypass, stent placement), device-related complications (device migration, stenosis or thrombosis and kinking), endoleaks (combined and type-specific), rupture and aneurysmal growth was not increased in any of the groups with adjuvant procedures ( 
Discussion
The relatively high prevalence of adjuvant procedures (29.2% overall) in this EUROSTAR series is comparable to other studies. [8] [9] [10] A higher ASA classification was predictive of adjuvant procedures. This may be explained by a higher frequency of adverse anatomic characteristics in patients with comorbid factors. Female gender appeared to be an additional risk factor for surgical adjuvant procedures. This observation is in agreement with the findings of Wolf et. al. who reported a higher incidence of arterial reconstructions and access difficulties because of smaller arteries in women. 17 The largest category of adjuvant procedures consisted of endovascular procedures (group A, 78.1%). This kind of procedure demonstrated a higher incidence of early complications of arterial and systemic origin. However, the incidence of major events, such as mortality, conversion and rupture was not significantly different. It was of note that primary conversion to open surgery on the first day was less frequently observed in patients with adjuvant transfemoral procedures (group A) compared with patients without. The commonest cause of primary conversion is access failure. 18 Before the decision is taken to convert the procedure, quite frequently endovascular adjuvant procedures are attempted to overcome the access problem and other pitfalls. Adjuvant procedures were either planned or unexpectedly required to resolve intraoperative complications. Because of this, it was of no surprise that early procedural outcome was associated with the group assignment. We did not consider intraoperative events in this analysis.
None of the severe late adverse outcomes, such as mortality, conversion or rupture rate was significantly increased in the patients with endovascular adjuvant procedures. Thus, the application of endovascular adjuvant procedures may be considered as a relatively safe option. However, previous studies are not all in agreement with this conclusion. For instance it has been noted that certain complications such as pelvic ischaemia has occurred more frequent after coil embolisation of a hypogastric artery in patients with common iliac aneurysms. 9, 19 Surgical peripheral arterial adjuvant procedures (group B) were associated with a higher rate of early perioperative complications than un-assisted cases. The observed increase in hepatobiliary and bowel systemic complications in this group of patients cannot readily be explained. Moreover, a 10-fold increase in prevalence of postoperative predischarge arterial thrombosis was observed in this category, a four-fold increase in peripheral emboli and a six-fold increase in occlusion of the renal artery. An increased thrombogenicity may explain the reasons for the adjuvant procedures as well as the thromboembolic complications. Moreover, any adjuvant surgical procedure may cause a systemic response perhaps resulting 83 P-values represent significant differences compared with group D.
repair in patients at high risk for a surgical adjuvant procedure. Conversion to open repair is associated with a higher operative mortality than initial elective open repair. 18 A recent publication recommended open repair in patients at high anatomic and low physical risk, while in patients at high anatomic and high medical risk endovascular repair with adjunct procedures to overcome these anatomic difficulties is recommended. 7 However, after the 30-day postoperative period, no increased incidence is expected in any of the studied adverse events, including mortality. The aneurysmrelated mortality is increased, however, this increase is mainly caused by the increased 30-day mortality rate rather than by late deaths. From the present study we may conclude that when surgical adjuvant procedures can be performed with acceptable initial morbidity and mortality, long term mortality is not increased.
Caution is warranted when using a registry. The risk of selection bias in the different study groups may influence the comparisons. There was a moderate discrepancy in the distribution of patient characteristics between groups. However, there is no reason to assume that the study findings are not valid, as the calculated odds ratios have been adjusted for these characteristics and preoperative measurements. The main selection bias may be that the use of adjuvant procedures allows endovascular surgery for aneurysms with a more complex anatomy and a widening of indications. 9, 10 Multi-centre studies generally report less favorable results than single-centre investigations. 22 Therefore, an underestimation of the mortality rate is less likely than an overestimation.
In conclusion, in the long term no adjuvant procedure was associated with an increased incidence of adverse events. Endovascular repair might not be recommended in patients expected to require surgical adjuvant procedures because of the increased 30-day mortality. However, endovascular adjuvant procedures may be regarded as low risk.
